BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 17, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Nov. 11, 2025

Nov. 11, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Avenzo, Boehringer, City, Tenaya, UCB, Vera.
Read More

Other news to note for Nov. 11, 2025

Nov. 11, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: AN2, Damora, Eli Lilly, Galecto, Genfit, GSK, Meiragtx, Teva, Transition, Voyager.
Read More

In the clinic for Nov. 11, 2025

Nov. 11, 2025
Clinical updates, including data readouts and publications: Adarx, Amgen, Anaptysbio, Apogee, Astrazeneca, Atai Beckley, Bioinvent, Bluejay, Camurus, Cogent, Inflarx, Ionis, Mannkind, Merck, Mineralys,  Neurogastrx, Novo Nordisk, Organon, Roche, Swedish Orphan Biovitrum, Vor.
Read More

Financings for Nov. 11, 2025

Nov. 11, 2025
Biopharmas raising money in public or private financings, including: Arch Biopartners, Evommune, Onchilles.
Read More

Appointments and advancements for Nov. 11, 2025

Nov. 11, 2025
New hires and promotions in the biopharma industry, including: Acumen, Alpha-9, Celldex, Nurix, Onchilles, Quralis, Simris.
Read More

Appointments and advancements for Nov. 11, 2025

Nov. 11, 2025
New hires and promotions in the med-tech industry, including: Veranex.
Read More

Financings for Nov. 11, 2025

Nov. 11, 2025
Med-tech firms raising money in public or private financings, including: Cornerstone Robotics.
Read More

In the clinic for Nov. 11, 2025

Nov. 11, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cleerly.
Read More

Other news to note for Nov. 11, 2025

Nov. 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Capsovision, Complete Genomics Fastwave, Knight Therapeutics, Profound Medical, Sectra, Sophia Genetics, Surmodics.
Read More

Regulatory actions for Nov. 11, 2025

Nov. 11, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Sterotaxis, Zap Surgical.
Read More
Previous 1 2 … 25 26 27 28 29 30 31 32 33 … 1718 1719 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Child pushing away bowl of peanuts

    Vitesse finesse pays off: DBV wins in peanut allergy phase III

    BioWorld

    DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....

  • Handshake with tech background

    Harbour Biomed closes busy year with $1B+ BMS deal

    BioWorld
    Harbour Biomed has added another collaboration to its end-of-year dealmaking, this time with Bristol Myers Squibb Co. (BMS) to develop multispecific antibodies....
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing